Computer Delivered and Community Health Worker Supported Smoking Cessation Intervention
- Conditions
- Tobacco Smoking
- Registration Number
- NCT04566159
- Lead Sponsor
- Johns Hopkins University
- Brief Summary
The prevalence of tobacco smoking is high among persons with HIV (PWH). The investigators are piloting a two session computer-delivered intervention (CBI) with linkage to a community health worker (CHW) among hospitalized PWH with tobacco use 1a) To determine feasibility and acceptability of delivering this intervention and 2a) To determine intervention effect on 1) readiness to quit smoking and confidence in ability to quit smoking 2) uptake of smoking cessation therapy
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 22
- Age >=18,
- A patient admitted to the Johns Hopkins Hospital
- Smoked >100 cigarettes in their lifetime
- Current smoker
- English speaking
- Contraindication to nicotine replacement therapy including unstable angina and acute coronary syndrome
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method Intervention Feasibility as assessed by the Feasibility of Intervention Measure 3 months 4 item scale, maximum score of 20 with higher score indicating greater feasibility
Intervention Acceptability as assessed by the Acceptability of an Intervention Measure 3 months Noted as continuous score on 4 item scale, maximum value of 20 with higher score indicating greater acceptability
- Secondary Outcome Measures
Name Time Method Uptake of nicotine replacement therapy immediately post intervention Dichotomous yes/no.
Continued use of nicotine replacement therapy 1 month post intervention 30 days post intervention Dichotomous yes/no.
Readiness to quit smoking as assessed by a Visual analog scale immediately post intervention Score of 10=Ready to Quit, Score of 1=Not ready to quit. Scale is from 1-10
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
Trial Locations
- Locations (1)
Johns Hopkins University
🇺🇸Baltimore, Maryland, United States
Johns Hopkins University🇺🇸Baltimore, Maryland, United States